首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   1412496篇
  免费   98034篇
  国内免费   2293篇
耳鼻咽喉   19958篇
儿科学   46127篇
妇产科学   41081篇
基础医学   206587篇
口腔科学   40186篇
临床医学   115941篇
内科学   281420篇
皮肤病学   30365篇
神经病学   110285篇
特种医学   53366篇
外国民族医学   367篇
外科学   212716篇
综合类   27168篇
现状与发展   1篇
一般理论   321篇
预防医学   108510篇
眼科学   32857篇
药学   108391篇
  1篇
中国医学   3020篇
肿瘤学   74155篇
  2018年   16072篇
  2017年   11566篇
  2016年   12682篇
  2015年   14504篇
  2014年   19218篇
  2013年   29348篇
  2012年   42110篇
  2011年   45040篇
  2010年   25679篇
  2009年   23296篇
  2008年   42354篇
  2007年   45864篇
  2006年   46153篇
  2005年   45050篇
  2004年   43093篇
  2003年   41610篇
  2002年   40860篇
  2001年   61722篇
  2000年   63621篇
  1999年   53771篇
  1998年   14794篇
  1997年   13178篇
  1996年   13413篇
  1995年   12652篇
  1994年   12016篇
  1992年   42699篇
  1991年   41855篇
  1990年   41404篇
  1989年   39999篇
  1988年   37362篇
  1987年   36486篇
  1986年   34895篇
  1985年   33222篇
  1984年   24715篇
  1983年   21481篇
  1982年   12741篇
  1981年   11252篇
  1979年   23599篇
  1978年   16532篇
  1977年   14363篇
  1976年   13579篇
  1975年   14932篇
  1974年   17562篇
  1973年   17014篇
  1972年   16205篇
  1971年   15117篇
  1970年   14034篇
  1969年   13624篇
  1968年   12886篇
  1967年   11280篇
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
41.
The aim of the present study was to evaluate the antimicrobial activity of two synbiotic combinations, Lactobacillus fermentum with short-chain fructooligosaccharides (FOS-LF) and Bifidobacterium longum with isomaltooligosaccharides (IMO-BL), against enterohaemorrhagic Escherichia coli O157:H7 and enteropathogenic E. coli O86. Antimicrobial activity was determined (1) by co-culturing the synbiotics and pathogens in batch cultures, and (2) with the three-stage continuous culture system (gut model), inoculated with faecal slurry from an elderly donor. In the co-culture experiments, IMO-BL was significantly inhibitory to both E. coli strains, while FOS-LF was slightly inhibitory or not inhibitory. Factors other than acid production appeared to play a role in the inhibition. In the gut models, both synbiotics effectively inhibited E. coli O157 in the first vessel, but not in vessels 2 and 3. E. coli O86 was not significantly inhibited.  相似文献   
42.
43.
44.

Background

Since recent reports have shown that (-)-Epigallocatechin-3-gallate (EGCG) could be used for treating proliferative and inflammatory disorders, we explored its use for the management of corneal chemical burns.

Materials and methods

Initially, EGCG was assayed on the rabbit corneal epithelial cell line RCE1(5T5) to establish the best testing conditions, and to avoid unwanted outcomes in the experimental animals. Then, we studied its effects on cell proliferation, cell cycle progression and cell differentiation. Afterwards, we instilled EGCG in experimental grade II corneal alkali burns in mice, three times a day up to 21 days, and evaluated by slit lamp examination and histological sections of corneal epithelial, corneal endothelial and stromal edema, as well as the presence of inflammatory cells and neovascularization.

Results

EGCG reduced cell growth and led to a decline in the proportion of proliferative cells in a concentration dependent manner. At 10 μM, EGCG promoted cell differentiation, an effect not related with apoptosis or cytotoxicity. When 10 μM EGCG was instilled in corneal alkali burns in mice three times a day up to 21 days, EGCG significantly reduced corneal opacity and neovascularization. The improved clinical appearance of the cornea was associated to a controlled epithelial growth; epithelial morphology was similar to that observed in normal epithelium and contrasted with the hyperproliferative, desquamating epithelium observed in control burn wounds. EGCG reduced corneal, stromal and endothelial edema, and wound inflammation.

Conclusion

This work constitutes the first evidence for the use of EGCG in the acute phase of a corneal alkali burn, representing a possible novel alternative to improve patient outcomes as an add-on therapy.  相似文献   
45.
46.
47.
48.
BackgroundThe aim of this paper is to assess the current state of quality and outcomes measures being reported for hepatic resections in the recent literature.MethodsMedline and PubMed databases were searched for English language articles published between 1 January 2002 and 30 April 2013. Two examiners reviewed each article and relevant citations for appropriateness of inclusion, which excluded papers of liver donor hepatic resections, repeat hepatectomies or meta-analyses. Data were extracted and summarized by two examiners for analysis.ResultsFifty-five studies were identified with suitable reporting to assess peri-operative mortality in hepatic resections. In only 35% (19/55) of the studies was the follow-up time explicitly stated, and in 47% (26/55) of studies peri-operative mortality was limited to in-hospital or 30 days. The time period in which complications were captured was not explicitly stated in 19 out of 28 studies. The remaining studies only captured complications within 30 days of the index operation (8/28). There was a paucity of quality literature addressing truly patient-centred outcomes.ConclusionQuality outcomes after a hepatic resection are inconsistently reported in the literature. Quality outcome studies for a hepatectomy should report mortality and morbidity at a minimum of 90 days after surgery.  相似文献   
49.
50.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号